Burnettramic Acid A aglycone

• CAT Number: I023821
• CAS Number: 2396676-46-1
• Molecular Formula: C35H61NO7
• Molecular Weight: 607.87
• Purity: 95%
• Synonyms: Burnettramic Acid A aglycone
• Target: Endogenous Metabolite
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (2Z,6R,8S)-6-hydroxy-2-[(E,2S,4R,15R,19R)-1,15,19,26-tetrahydroxy-2,4-dimethylhexacos-12-enylidene]-5,6,7,8-tetrahydropyrrolizine-1,3-dione
• InChI: InChI=1S/C35H61NO7/c1-26(23-27(2)33(41)32-34(42)31-24-30(40)25-36(31)35(32)43)17-12-8-5-3-4-6-9-13-18-28(38)20-16-21-29(39)19-14-10-7-11-15-22-37/h9,13,26-31,37-41H,3-8,10-12,14-25H2,1-2H3/b13-9+,33-32-/t26-,27+,28+,29-,30-,31+/m1/s1
• InChIKey: HNDKRVVXVFPDKH-ODPYIYSASA-N
• SMILES: C[C@H](CCCCCCC/C=C/C[C@@H](CCC[C@@H](CCCCCCCO)O)O)C[C@H](C)/C(=C/1\C(=O)[C@@H]2C[C@H](CN2C1=O)O)/O

Burnettramic Acid A aglycone（Cat No.:I023821）is a bioactive compound derived from certain species of the Burnet genus, known for its potential medicinal properties. It is an aglycone, meaning it is the non-sugar component of a glycoside molecule that has been cleaved from its sugar part. Burnettramic Acid A aglycone has demonstrated various biological activities, including antioxidant, anti-inflammatory, and antimicrobial effects. Researchers are investigating its potential as a lead compound for developing therapies against chronic diseases, including cancer and neurodegenerative disorders, although more studies are needed to confirm its clinical applications.